Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report
Takeno, Ayumu, Yamamoto, Masahiro, Notsu, Masakazu, Sugimoto, ToshitsuguVolume:
16
Language:
english
Journal:
BMC Endocrine Disorders
DOI:
10.1186/s12902-016-0148-0
Date:
December, 2016
File:
PDF, 770 KB
english, 2016